抗生素
流出
细菌
药品
青霉素
氯丙嗪
吩噻嗪
微生物学
化学
膜透性
多重耐药
质粒
药理学
生物
膜
生物化学
基因
遗传学
作者
Sujata G. Dastidar,Jette E. Kristiansen,Joséph Molnár,Leonard Amaral
出处
期刊:Antibiotics
[Multidisciplinary Digital Publishing Institute]
日期:2013-02-18
卷期号:2 (1): 58-72
被引量:50
标识
DOI:10.3390/antibiotics2010058
摘要
Phenothiazines have their primary effects on the plasma membranes of prokaryotes and eukaryotes. Among the components of the prokaryotic plasma membrane affected are efflux pumps, their energy sources and energy providing enzymes, such as ATPase, and genes that regulate and code for the permeability aspect of a bacterium. The response of multidrug and extensively drug resistant tuberculosis to phenothiazines shows an alternative therapy for the treatment of these dreaded diseases, which are claiming more and more lives every year throughout the world. Many phenothiazines have shown synergistic activity with several antibiotics thereby lowering the doses of antibiotics administered to patients suffering from specific bacterial infections. Trimeprazine is synergistic with trimethoprim. Flupenthixol (Fp) has been found to be synergistic with penicillin and chlorpromazine (CPZ); in addition, some antibiotics are also synergistic. Along with the antibacterial action described in this review, many phenothiazines possess plasmid curing activities, which render the bacterial carrier of the plasmid sensitive to antibiotics. Thus, simultaneous applications of a phenothiazine like TZ would not only act as an additional antibacterial agent but also would help to eliminate drug resistant plasmid from the infectious bacterial cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI